The 20 Best Malignant Mixed Mullerian Tumor Doctors Near Me in New Hyde Park, NY

Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Jill Whyte is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Whyte is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Carcinosarcoma, Adult Soft Tissue Sarcoma, Oophorectomy, and Salpingo-Oophorectomy. Dr. Whyte is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

"Andrew Menzin, MD, is an OB/GYN and oncology specialist at Northwell Health Physician Partners Gynecologic Oncology at New Hyde Park. He is also the chief of gynecologic oncology for Northwell facilities across central Long Island and Queens, and the vice chairman of academic affairs for the OB/GYN service line. Dr. Menzin has nearly three decades of experience in gynecologic oncology and academic medicine.""I come from a family of doctors,"" he says. ""Education, medicine and service to others was just part of how I grew up.""Dr. Menzin treats the full spectrum of gynecologic issues, from benign conditions to all malignancies of the female reproductive system. His extensive surgical expertise includes cancer surgery, robotic surgery and complex gynecologic surgery.He joined Northwell Health in 1995, after completing a fellowship in gynecologic oncology and a residency in obstetrics and gynecology at the Hospital of the University of Pennsylvania.""At Northwell, we're here to meet every patient's needs and deliver truly collaborative care,"" says Dr. Menzin, who works closely with specialists including pathologists, radiologists, medical oncologists, radiation oncologists, general surgeons, colorectal surgeons and urologists. He carefully explains this multifaceted care to each patient-even drawing his unique diagrams for extra clarity.Dr. Menzin is a professor of obstetrics and gynecology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is a member of the Society of Gynecologic Oncology, as well as a fellow of the American College of Surgeons and the American College of Obstetricians and Gynecologists. He's been named numerous times on the Castle Connolly Top Doctors list, and he's an avid supporter of the National Ovarian Cancer Coalition, which supports ovarian cancer survivors and funds research to find a cure.""I have had great mentors who've inspired me along the way,"" says Dr. Menzin. ""It's all about delivering care that's patient-centered. Looking after them the way I'd want to be cared for.""". Dr. Menzin is rated as a Distinguished provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Hernia Surgery, and Hysterectomy. Dr. Menzin is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Richard Barakat is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Barakat is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vulvar Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Barakat is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Kit Cheng, MD, is the Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she is committed to the recruitment and education of future generations of physicians. Board certified in Internal Medicine, Hematology and Medical Oncology, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As an attending physician based at the Monter Cancer Center, Dr. Cheng specializes in breast cancer and gynecology oncology, namely cervical cancer, endometrial cancer, ovarian cancer, uterine cancer and vaginal cancer. She is a principal investigator and sub principal investigator in multiple breast and gynecologic oncology clinical trials. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Cheng earned her medical degree at the State University of New York at Buffalo. She trained in Internal Medicine and Hematology/Oncology at North Shore University Hospital where she was also Chief Fellow. Dr. Cheng is an active member of the American Society of Clinical Oncology and is fluent in Cantonese and English. Dr. Cheng is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Cheng is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Kevin Holcomb is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Holcomb is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Cervical Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Holcomb is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Joan Tymon is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Tymon is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ovarian Carcinosarcoma, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Tymon is board certified in American Board Of Obstetrics & Gynecology.

Karin Shih is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Shih is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, Hysterectomy, and Oophorectomy. Dr. Shih is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Marina Frimer is an Oncologist practicing medicine in New Hyde Park, New York. Dr. Frimer is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy. Dr. Frimer is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Dr. Mark A. Hoffman is the Section Head of Hematology at Long Island Jewish's Division of Hematology/Oncology. Dr. Hoffman is also an Associate Professor of Clinical Medicine at Albert Einstein College of Medicine and was listed as one of the Best Doctors in America, from 2003 through 2007. His interests include breast cancer, gynecologic malignancies, chronic lymphocytic leukemia and malignant lymphomas. Dr. Hoffman is also focused on the development of communication skills in oncology and supportive care. Dr. Hoffman is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Endometrial Cancer, Adult Soft Tissue Sarcoma, and Inflammatory Breast Cancer.

"Dr. Iris Wertheim attended Columbia University College of Physicians and Surgeons, and completed her residency and fellowship training at Brigham and Women's Hospital. She is a diplomate of the American Board of Obstetrics & Gynecology in the specialties of obstetrics and gynecology and gynecologic oncology. She joined our Medical Staff in 2002, and is Director of the Gynecologic Oncology program. Dr. Wertheim has been awarded the Planetree Physician of the Year for her patient-centered care. Dr. Wertheim was recognized as having a ""special presence with all of her patients"" and that ""every time she makes rounds, she takes the time to sit down in their room, listens attentively, and proactively reacts to each and every request.""". Dr. Wertheim is rated as an Advanced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, and Testicular Yolk Sac Tumor. Dr. Wertheim is board certified in American Board Of Obstetrics & Gynecology and American Board Of Obstetrics & Gynecology-Gynecologic Oncology.

Eileen Sheehy-Milano,MD is an attending physician based at the Monter Cancer Center where she has special interests in breast cancer and gastrointestinal cancer. Board certified in Internal Medicine and Medical Oncology, she maintains an active practice where she focuses on compassionate, personalized, evidence based multi-disciplinary care. Prior to moving her practice to the Monter Cancer Center, Dr. Sheehy-Milano practiced for 25 years at Northwell Glen Cove Hospital. She earned her medical degree at the Jefferson College for Health Professions in Philadelphia,Pennsylvania. She trained in Internal Medicine at St. Francis Hospital and Medical Center in Hartford, Connecticut with a chief residency year as part of the U. Conn. health system. She completed a fellowship in Medical Oncology at Baylor College of Medicine in Houston, Texas. An active member of the American Society of Clinical Oncology and the American Medical Association, Dr. Sheehy-Milano is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Milano is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Anemia, Breast Cancer, and Paget Disease of the Breast. Dr. Milano is board certified in American Board Of Internal Medicine/Medical Oncology.

Noah Kauff is an Obstetrics and Gynecologist practicing medicine in Lake Success, New York. Dr. Kauff is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, DICER1 Syndrome, BRCA Positive Breast Cancer, Oophorectomy, and Salpingo-Oophorectomy. Dr. Kauff is board certified in American Board Of Obstetrics & Gynecology.

Dr. Carleton, MD, is Associate Chief of the R.J. Zuckerberg Cancer Center at the Northwell Health Cancer Institute. Dr. Carleton, an expert in the treatment of breast cancer, joined the staff at North Shore University Hospital in 2002. A Massachusetts native, Dr. Carleton graduated from the University of Massachusetts Medical School and completed both her residency in Internal Medicine and fellowship in Hematology/Oncology at Tufts Medical Center in Boston. She then conducted two years of hematology research at the Beth Israel Deaconess Medical Center in Boston. Since joining the Northwell Health System she has focused her career primarily on breast cancer, including breast cancer prevention and the management of early stage and advanced breast cancer. She is actively involved in multidisciplinary disease oriented care models for these diseases. In addition to patient care she is actively involved in the education of medical students, residents and fellows, and participates in clinical research on breast cancer. She is an Assistant Professor of Medicine at the Hofstra Northwell School of Medicine. Dr. Carleton is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Carleton is board certified in American Board Of Internal Medicine/Medical Oncology.

As Director of Quality and Patient Safety for Medical Oncology at the Monter Cancer Center, Dr. Tony Philip is committed to improving clinical outcomes. Board Certified in Hematology and Medical Oncology, Dr. Philip s clinical practice is solely dedicated to the treatment of patients with gastrointestinal cancers and sarcomas (cancers of the soft tissue and bone). He maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He participates in research focused on improving the care of patients with these diseases. Currently an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Philip completed his Hematology/Oncology fellowship at North Shore-LIJ and his internal medicine residency at Long Island Jewish Medical Center. Dr. Philip earned his MD at University at Buffalo School of Medicine and Biomedical Sciences. He is an active member of the American Society of Clinical Oncology, Connective Tissue Oncology Society, and American College of Physicians. Dr. Philip completed the Northwell Physician Leadership Development Program and the American Society of Clinical Oncology Quality Program. Dr. Philip is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Rhabdomyosarcoma Embryonal, Adult Soft Tissue Sarcoma, and Colorectal Cancer. Dr. Philip is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Savona is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. Crina Vintila is an attending physician double board-certified in medical oncology and hematology, who has served the Long Island community for more than 20 years at the Don Monti Cancer Center at Glen Cove Hospital, Huntington Cancer Institute, and most recently, at the Monter Cancer Center.Being part of the Northwell Health System for more than 2 decades, her practice has focused on delivering individualized, evidence-based patient care, in a multidisciplinary setting, with active participation in research trials. She takes special interest in breast, gastrointestinal, and hematologic malignancies.Dr.Vintila earned her medical degree at the Institute of Medicine and Pharmacy, Bucharest, Romania. She completed internal medicine training at the Weil Cornell / NY Hospital -Booth Memorial Medical Center, and her hematology and medical oncology fellowship at Winthrop University Hospital.Dr.Vintila is fluent in Romanian, Spanish and French. Dr. Vintila is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer. Dr. Vintila is board certified in American Board Of Internal Medicine/Medical Oncology.

Ruby Sharma, MD, is an attending at the Monter Cancer Center where her clinical practice is solely dedicated to the treatment of patients with breast cancer. She maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board Certified in Internal Medicine, Medical Oncology, Hematology and Palliative Medicine, she is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Her research is focused on the prevention of disease, prevention of recurrence after surgery, and treatment of recurrences. She has a special interest in triple negative breast cancer and breast cancer diagnosed during pregnancy. Dr. Sharma is a member of the New York Metropolitan Breast Cancer Group, the American Society of Clinical Oncology, the American College of Physicians, American Society of Hematology and American Academy of Hospice and Palliative Medicine. She meets weekly with the interdisciplinary Breast Cancer Tumor Board, where challenging cases are reviewed. In addition to patient care, she is actively involved in the education of medical students, residents and fellows. Dr. Sharma is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. Dr. Sharma is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Maria Jacqueline Nieto,MD,MSc is an Assistant Professor of Medicine at The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell where she specializes in treating patients with benign and malignant hematological conditions.Dr Nieto is board certified in Internal Medicine and Medical Oncology. Dr Nieto's clinical focus is on myelodysplastic syndromes, myeloproliferative disorders, and lymphomas. She is particularly interested in the care of the elderly with hematological malignancies, evaluating treatment disparities in cancer care, and optimizing cancer and palliative care at the end of life. She is co-investigator on multiple clinical trials focused on the treatment of patients with hematological malignancies. Dr Nieto has a Master of Science degree in Clinical Research from New York University.Dr Nieto is an active member in the American Society of Clinical Oncology and the American Society of Hematology and is fluent in Spanish. Dr. Nieto is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Bone Marrow Aspiration, and Tissue Biopsy.

Nouneh Gostanian is an Oncologist practicing medicine in Lake Success, New York. Dr. Gostanian is rated as an Experienced provider by MediFind in the treatment of Malignant Mixed Mullerian Tumor. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Drug-Induced Thrombocytopenia, and Inflammatory Breast Cancer. Dr. Gostanian is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.